Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies

Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies

Introduction: SARS-CoV-2 is a RNA virus that associates with heterogeneous clinical manifestations and complications. Auto-antibodies are identified in approximately 50% of hospitalized COVID-19 patients. Objectives: To determine the global incidence of myositis-related auto-antibodies (non Jo1-RNA...

Full description

Bibliographic Details
Main Authors: Laura García-Bravo, Myriam Calle-Rubio, Miguel Fernández-Arquero, Kauzar Mohamed Mohamed, Teresa Guerra-Galán, María Guzmán-Fulgencio, Antonia Rodríguez de la Peña, Cristina Cañizares, Bárbara López, Cristina Vadillo, Jorge Matías-Guiu, Asunción Nieto Barbero, José Luis Álvarez-Sala Walther, Silvia Sánchez-Ramón, Juliana Ochoa-Grullón
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Journal of Translational Autoimmunity
Subjects:
Myositis
Interstitial lung disease
Myositis specific antibodies
COVID19
SARS-CoV-2 vaccines
Online Access:http://www.sciencedirect.com/science/article/pii/S2589909022000211

Internet

http://www.sciencedirect.com/science/article/pii/S2589909022000211

Similar Items